Resources Contact Us Home
Clostridium perfringens alpha toxin proteins

Image Number 6 for United States Patent #7982006.

This invention pertains in part to the development of a vaccine for poultry against necrotic enteritis (NE). The vaccine utilizes a protective antigen that is a mutated, full-length, non-toxic Clostridium perfringens (Cp) .alpha.-toxin protein (Mcpa). Utility of this vaccine was demonstrated by reduction of lesion severity in NE challenge trails, for example. Also disclosed herein are novel approaches for producing this vaccine in significant quantities. One exemplified approach involves producing NE vaccine (mutated alpha toxin) in bacterial expression systems, preferably utilizing the Pseudomonas fluorescens system, for commercial use in controlling NE in the poultry industry. The subject vaccines can be administered preferably to chickens in several different ways. A novel, Type VI alpha toxin from chicken isolates of Cp is also disclosed.

  Recently Added Patents
Web-based royalty system and user interface
Methods of reverse link power control
Base station device and wireless communication method
Dynamic reconstruction of a calibration state of an absorption spectrometer
Use of emerging non-volatile memory elements with flash memory
System and method of detecting and locating intermittent and other faults
Plants and seeds of corn variety CV092363
  Randomly Featured Patents
Trackway segment for toy vehicle trackway-system
Device for automatically identifying catenary posts of a railway track to locate faults detected on the railway track
Esterified triclosan derivatives as improved textile antimicrobial agents
Electrical connector
Method and apparatus for treating textile cord
Upper hitch link electronic draft sensing
Stabilizing aqueous anionic resinous dispersions with chelating agents
Printing and display device incorporating at least two printheads
Automatic speed adjusting fishing reel
Combination quick connect-disconnect pneumatic/electrical coupling